Cargando…
Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase
AIM: To develop a non-invasive model to evaluate significant fibrosis and cirrhosis by investigating the association between serum ceruloplasmin (CP) levels and liver fibrosis in chronic hepatitis B (CHB) patients with normal or minimally raised alanine aminotransferase (ALT). METHODS: Serum samples...
Autores principales: | Zeng, Da-Wu, Dong, Jing, Jiang, Jia-Ji, Zhu, Yue-Yong, Liu, Yu-Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116602/ https://www.ncbi.nlm.nih.gov/pubmed/27920479 http://dx.doi.org/10.3748/wjg.v22.i43.9586 |
Ejemplares similares
-
Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients
por: Kang, Na-Ling, et al.
Publicado: (2020) -
Declining diagnostic accuracy of non-invasive fibrosis tests is associated with elevated alanine aminotransferase in chronic hepatitis B
por: Wang, Lin, et al.
Publicado: (2018) -
Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase
por: Tan, You-Wen, et al.
Publicado: (2017) -
Spleen thickness can predict significant liver pathology in patients with chronic hepatitis B with persistently normal alanine aminotransferase or minimally raised alanine aminotransferase: a retrospective study
por: Zhang, Junli, et al.
Publicado: (2018) -
Use of aspartate aminotransferase to platelet ratio to reduce the need for FibroScan in the evaluation of liver fibrosis
por: Wong, Stephanie, et al.
Publicado: (2017)